Thesis (M.A.)--Kutztown University of Pennsylvania, 1999. / Source: Masters Abstracts International, Volume: 45-06, page: 2778. Typescript. Abstract included as two unpaged leaves at back of volume. Includes bibliographical references (leaves 30-35).

Thesis (Ph. D.)--University of California, San Diego and San Diego State University, 2010. / Available via ProQuest Digital Dissertations. Vita. Includes bibliographical references (leaves 69-80).

Thesis (Ph. D.)--West Virginia University, 2007. / Title from document title page. Document formatted into pages; contains vi, 75 p. Includes abstract. Includes bibliographical references (p. 48-54).

Smoking patterns were described and compared retrospectively for 5395 participants in the Lung Health Study at 12 and 24 months. 3592 participants were assigned to a special intervention (SI) group that received a counseling assisted smoking cessation intervention that included nicotine gum and 1803 participants were assigned to a usual care (UC) group that received no assistance in quitting smoking. Participants were smokers diagnosed with mild to moderate chronic obstructive pulmonary disease (COPD) and averaged 31.4 cigarettes/day at entry. Significant differences were found regarding smoking outcomes and smoking patterns between groups as well as within each group. Counseling assisted participant's continuous abstinence rate at 24 months was 25.1% compared to 3.5% for unassisted smokers. Counseling assisted men were more successful at remaining abstinent at 24 months (27.1%) compared to (21.8%) for counseling assisted women. No gender differences were found for unassisted smokers. Abstinence rates were biochemically validated. Differences were also found in smoking patterns between groups for those unable to achieve continuous abstinence at 24 months. Counseling assisted participants smoked fewer cigarettes, made more quit attempts, smoked fewer months and stayed quit longer. Mixed results were found for baseline demographic and smoking history variables. Age started smoking, other smokers in the household, education and social support were not significant. Cigarettes smoked per day, previous quit attempts, longest period quit and alcoholic drinks per week were significant. / Graduation date: 1992

Thesis (M. Phil.)--University of Hong Kong, 2002. / Includes bibliographical references (leaves 119-155).

This study investigated the relationship between smoking cessation and cognitive factors of attributional style, self-efficacy and locus of control. The roles of examined as they contributed to the prediction of smoking status. Questionnaires designed to measure these cognitivevariables, were administered to participants of smoking cessation programs at two times during the study; immediately before participation in the smoking cessation program and immediately after completion of the program. Smoking status was assessed at these times, as well as via telephone twice after the program's completion. Subjects were obtained from 16 American Cancer Society smoking cessation clinics in the Southern California area. The results of stepwise discriminant analyses of variance successfully predicted smoking status at end-of-clinic and follow-up periods, using a combination of demographic, smoking behavior and cognitive predictors. Cross-validations of the predictive models also were able to predict smoking status at end-of-clinic and follow-up. Additional analyses included stepwise discriminant demographic and smoking behavior variables styles, as well as demographic and smoking behavior Cognitive Factors 5 analyses of participants who relapsed at follow-up, and a comparison of those who completed the program versus those who dropped out prematurely. Both analyses resulted in obtaining significant discriminant functions. A final analysis compared pre- and post-treatment responses on the cognitive measures via a 2 X 2 multiple analysis of variance (group X time). A significant interaction between group and time of assessment was obtained. / Department of Counseling Psychology and Guidance Services

Thesis (M.A.)--University of Missouri-Columbia, 2008. / The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Title from title screen of research.pdf file (viewed on September 8, 2008) Includes bibliographical references.

Thesis (M.A.)--University of Texas at El Paso, 2009. / Title from title screen. Vita. CD-ROM. Includes bibliographical references. Also available online.

No description available.

Previous studies have found that smoking may have a negative effect on vitamin B-6 indices and have demonstrated a possible association between smoking and depressed plasma pyridoxal-5'-phosphate (PLP) concentration. Individuals with plasma PLP values below the adequate level of 30 nmoles/L might benefit from consumption of vitamin B-6 supplements, but no data are available on vitamin B-6 status in smokers consuming a controlled vitamin B-6 intake and receiving a vitamin B-6 supplement. The objectives of this research were to assess vitamin B-6 status in smokers as compared to non-smokers receiving a controlled diet and to evaluate the effect of an oral vitamin B-6 supplementation in these subjects. The vitamin B-6 (B-6) status of 5 (four males / one female) smokers (S) and 4 (three males / one female) non-smokers (NS) was assessed. A constant diet was fed for 20 days and provided 1.95 mg of B-6 or 1.65 mg of B-6 for males and females, respectively. For the last 10 days, an additional 2-mg of pyridoxine (PN) was given daily. Blood samples were collected on days 1.7, 11.14 and 21; and 24 hour urine samples were collected daily. Urinary 4-pyridoxic acid (4-PA) and total B-6 (UB6) excretion, plasma B-6 vitamers (PLP, PN, pyridoxal and 4-PA) and red blood cell PLP (RBC PLP) concentrations, as well as plasma alkaline phosphatase activity (APA) were determined. Mean plasma PLP, 4-PA, and RBC PLP concentrations were significantly lower (P [less than or equal to] 0.05) at all time points in S compared to NS. With a daily supplement of 2-mg vitamin B-6, the mean plasma PLP concentration of S increased 85.8% but was 48.5% lower than that of NS consuming 1.65-1.95 mg/d of B-6. Mean plasma pyridoxal concentrations were not different between S and NS before and after supplementation. Excretion of 4-PA was not significantly different between S and NS, but the mean values of 4-PA excretion were consistently greater in NS compared to that of S throughout the 20-day study. The percent of ingested B-6 excreted as 4-PA for the S and NS was 38 and 49 in the non-supplemented period, and 47 and 53 in the supplemented period, respectively, indicating that non-smokers excreted more 4-PA than smokers. However, the difference in 4-PA excretion between S and NS was not significantly different both before and after supplementation (P>0.05). In addition, there was no significant difference between S and NS for plasma PN concentration, AP, and UB6 excretion for both periods. Results suggested an adverse effect of smoking on B-6 metabolism, thus an increased requirement of vitamin B-6 in smokers. A 2-mg PN supplement was sufficient to bring the concentration of plasma PLP in smokers to the level suggested as adequate, but it didn't bring it to the level of non-smokers. / Graduation date: 1999